Release date: 2009-07-14 Researchers at Monash University in Australia announced on the 8th that they found that obesity triggers the mechanism of type 2 diabetes. This result has helped to develop drugs for the treatment of type 2 diabetes. Dongguan Anmeixuan Electronic Technology Co., Ltd , https://www.hyashine.com
The researchers found that fat cells release a protein called pigment epithelium-derived factor (PEDF), which causes muscle and liver to become less sensitive to insulin, so the pancreas can only produce more insulin. Counteract the resulting negative effects. Over time, the pancreas is “overworked†and “overworkedâ€, and finally it may slow down or even stop producing insulin. But the researchers believe that this process is reversible, by preventing the pigment epithelium-derived factor from acting, the body can restore insulin to a sensitive state, thus eliminating the need for excess insulin to regulate blood sugar in the body.
The study was led by Matthew Watt, an associate professor of physiology at Monash University, and the results were published in the new US issue of Cell-Metabolism. Watt believes that this research will help scientists develop new drugs for the treatment of type 2 diabetes.
Diabetes is divided into type I diabetes, type 2 diabetes, and gestational diabetes. The cause of type I diabetes is mainly insulin deficiency. The cause of type 2 diabetes is mainly insulin-insensitive. Gestational diabetes is mainly caused by hormones secreted by women during pregnancy. Meditech Medical Network